Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $147.17 million. The enterprise value is $125.98 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 80.42 million shares outstanding. The number of shares has increased by 15.89% in one year.
| Current Share Class | 80.42M |
| Shares Outstanding | 80.42M |
| Shares Change (YoY) | +15.89% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 10.56% |
| Owned by Institutions (%) | 17.85% |
| Float | 61.41M |
Valuation Ratios
The trailing PE ratio is 26.49 and the forward PE ratio is 10.46.
| PE Ratio | 26.49 |
| Forward PE | 10.46 |
| PS Ratio | 2.26 |
| Forward PS | 1.94 |
| PB Ratio | 2.78 |
| P/TBV Ratio | 2.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 23.36 |
| EV / Sales | 2.04 |
| EV / EBITDA | 16.19 |
| EV / EBIT | 19.79 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.03 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | n/a |
| Interest Coverage | 7.82 |
Financial Efficiency
Return on equity (ROE) is 12.64% and return on invested capital (ROIC) is 8.02%.
| Return on Equity (ROE) | 12.64% |
| Return on Assets (ROA) | 5.53% |
| Return on Invested Capital (ROIC) | 8.02% |
| Return on Capital Employed (ROCE) | 10.56% |
| Revenue Per Employee | $290,329 |
| Profits Per Employee | $25,324 |
| Employee Count | 213 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.37 |
Taxes
In the past 12 months, PLX has paid $1.09 million in taxes.
| Income Tax | 1.09M |
| Effective Tax Rate | 16.81% |
Stock Price Statistics
The stock price has increased by +7.02% in the last 52 weeks. The beta is -0.27, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | -0.27 |
| 52-Week Price Change | +7.02% |
| 50-Day Moving Average | 2.17 |
| 200-Day Moving Average | 2.01 |
| Relative Strength Index (RSI) | 38.47 |
| Average Volume (20 Days) | 573,371 |
Short Selling Information
The latest short interest is 4.16 million, so 5.17% of the outstanding shares have been sold short.
| Short Interest | 4.16M |
| Short Previous Month | 4.15M |
| Short % of Shares Out | 5.17% |
| Short % of Float | 6.77% |
| Short Ratio (days to cover) | 3.88 |
Income Statement
In the last 12 months, PLX had revenue of $61.84 million and earned $5.39 million in profits. Earnings per share was $0.07.
| Revenue | 61.84M |
| Gross Profit | 35.58M |
| Operating Income | 6.37M |
| Pretax Income | 6.48M |
| Net Income | 5.39M |
| EBITDA | 7.78M |
| EBIT | 6.37M |
| Earnings Per Share (EPS) | $0.07 |
Full Income StatementBalance Sheet
The company has $29.37 million in cash and $8.18 million in debt, giving a net cash position of $21.19 million or $0.26 per share.
| Cash & Cash Equivalents | 29.37M |
| Total Debt | 8.18M |
| Net Cash | 21.19M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 52.91M |
| Book Value Per Share | 0.66 |
| Working Capital | 44.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.03 million and capital expenditures -$1.66 million, giving a free cash flow of -$11.69 million.
| Operating Cash Flow | -10.03M |
| Capital Expenditures | -1.66M |
| Free Cash Flow | -11.69M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
Gross margin is 57.54%, with operating and profit margins of 10.30% and 8.72%.
| Gross Margin | 57.54% |
| Operating Margin | 10.30% |
| Pretax Margin | 10.49% |
| Profit Margin | 8.72% |
| EBITDA Margin | 12.58% |
| EBIT Margin | 10.30% |
| FCF Margin | n/a |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.89% |
| Shareholder Yield | -15.89% |
| Earnings Yield | 3.67% |
| FCF Yield | -7.94% |
Analyst Forecast
The average price target for PLX is $12.00, which is 555.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 555.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PLX has an Altman Z-Score of -1.89 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.89 |
| Piotroski F-Score | 5 |
